Panaxia Labs (Israel) Today
| HROD Stock | 4,444 136.00 2.97% |
Performance0 of 100
| Odds Of DistressLess than 29
|
Panaxia Labs is trading at 4444.00 as of the 12th of December 2024, a 2.97 percent decrease since the beginning of the trading day. The stock's open price was 4580.0. Panaxia Labs has about a 29 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 12th of November 2024 and ending today, the 12th of December 2024. Click here to learn more.
Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company was incorporated in 2016 and is based in Lod, Israel. HERODIUM INVEST is traded on Tel Aviv Stock Exchange in Israel. More on Panaxia Labs Israel
Moving against Panaxia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Panaxia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Panaxia Labs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Panaxia Labs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Other, Other (View all Sectors) |
Panaxia Labs Israel (HROD) is traded on Tel Aviv Stock Exchange in Israel . The company currently falls under 'Micro-Cap' category with a current market capitalization of 57.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Panaxia Labs's market, we take the total number of its shares issued and multiply it by Panaxia Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Panaxia Labs Israel operates under Other sector and is part of Other industry.
Panaxia Labs Israel has accumulated about 2.6 M in cash with (1.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83.
Check Panaxia Labs Probability Of Bankruptcy
Panaxia Labs Israel Risk Profiles
Although Panaxia Labs' alpha and beta are two of the key measurements used to evaluate Panaxia Labs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.71 | |||
| Standard Deviation | 3.76 | |||
| Variance | 14.1 | |||
| Risk Adjusted Performance | (0.01) |
Panaxia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Panaxia Labs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Other Information on Investing in Panaxia Stock
Panaxia Labs financial ratios help investors to determine whether Panaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Panaxia with respect to the benefits of owning Panaxia Labs security.